Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.10 USD
Change Today +0.004 / 4.40%
Volume 19.1K
AFFY On Other Exchanges
As of 8:10 PM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

affymax inc (AFFY) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/6/15 - $0.18
52 Week Low
10/31/14 - $0.05
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AFFYMAX INC (AFFY)

affymax inc (AFFY) Related Businessweek News

No Related Businessweek News Found

affymax inc (AFFY) Details

Affymax, Inc. operates as a biopharmaceutical company in the United States. The company was founded in 2001 and is based in Cupertino, California.

2 Employees
Last Reported Date: 07/31/14
Founded in 2001

affymax inc (AFFY) Top Compensated Officers

Chief Financial Officer and Secretary
Total Annual Compensation: $97.5K
Compensation as of Fiscal Year 2013.

affymax inc (AFFY) Key Developments

Affymax, Inc. Declares Special Cash Distribution, Payable on or About December 23, 2014; Appoints Jonathan M. Couchman as Class I Director, President and Chief Executive Officer

Affymax, Inc. announced that its board of directors has declared a special cash distribution to shareholders in the amount of $0.05 per share. The special cash distribution will be paid to shareholders of record at the close of business on December 2, 2014, the record date, on or about December 23, 2014. The board has also appointed Jonathan M. Couchman as a Class I director of the company and as its President and Chief Executive Officer, and the remaining members of the board have resigned. The company, under the leadership of Mr. Couchman, will continue its evaluation of strategic alternatives. Jonathan M. Couchman serves as Chairman of the Board, Chief Executive Officer and Chief Financial Officer of Xstelos Holdings, Inc., and Myrexis, Inc. and previously served as Director of Golf Trust of America, during its evaluation of strategic alternatives, which culminated in the reverse merger of privately owned Pernix Therapeutics Holdings, Inc. into Golf Trust of America, effective March 9, 2010.

Affymax Seeks Acquisitions

Affymax, Inc. (OTCPK:AFFY) is looking for acquisitions. Jonathan M. Couchman, President and Chief Executive Officer of Affymax said, ""I appreciate the opportunity to continue to pursue strategic opportunities to further maximize value for shareholders, including the potential to make new investments and acquisitions among other alternatives".

Affymax Files Form 15

Affymax, Inc. announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Common Stock, par value $0.001 per share under the Securities Exchange Act of 1934, as amended.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AFFY:US $0.10 USD +0.004

AFFY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AFFY.
View Industry Companies

Industry Analysis


Industry Average

Valuation AFFY Industry Range
Price/Earnings 1.1x
Price/Sales 81.2x
Price/Book 0.7x
Price/Cash Flow 1.1x
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AFFYMAX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at